{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:10:26Z","timestamp":1771506626106,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Human\n                      <jats:italic>RAD50<\/jats:italic>\n                      gene mutations cause Nijmegen Breakage Syndrome-like disease, characterized by severe prenatal and postpartum growth retardation and microcephaly. It is very rare (less than 5 cases) with limited clinical data and treatment experience.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical information was collected on a boy with microcephaly and severe growth restriction, including birth history, clinical features, unplanned response to recombinant human growth hormone treatment, and five-year follow-up after growth hormone discontinuation. The child underwent trio-based whole-exome sequencing and Sanger sequencing to validate the mutation. Constructed variant plasmids were used for\n                      <jats:italic>in vitro<\/jats:italic>\n                      functional experiments and Western blots to evaluate the potential impact of the variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The boy was born at full term, with substantial growth retardation from infancy to early childhood. At the age of 4.5 years, the child with syndromic short stature was prescribed recombinant human growth hormone for height correction by junior resident physicians, with no genetic evaluation performed prior to treatment. After 5 years and 9 months of recombinant human growth hormone treatment, genetic analysis was done due to his evident microcephaly and distinctive facial features. Two novel variants (p.His1269Argfs2 and p.Ser844Asn) were identified in the\n                      <jats:italic>RAD50<\/jats:italic>\n                      gene. Western blotting revealed the presence of the Flag-tag and EGFP in RAD50-wt, but not in RAD50-mut (p.His1269Argfs2), indicating the frameshift mutation may markedly impair RAD50 protein expression or stability. Although recombinant human growth hormone significantly improved the patient\u2019s growth rate (from -3.35 SD to -1.28 SD), these variants may serve as a potential molecular basis for Nijmegen Breakage Syndrome-like disease and could also increase the risk of tumor formation. Treatment with recombinant human growth hormone was discontinued when the patient was 10 years and 3 months old. A five-year follow-up showed no evidence of a tumor was observed; The 15-year-old patient's height ceased to increase and remained at 151.5 cm.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In the current study, we identified and characterized a patient with two\n                      <jats:italic>RAD50<\/jats:italic>\n                      mutations. This report expands the clinical and genetic scope of\n                      <jats:italic>RAD50<\/jats:italic>\n                      mutations. For the first time, it describes the response to unplanned recombinant human growth hormone therapy and the risk of long-term tumors. This report is intended to raise clinical awareness of the risk-benefit balance of recombinant human growth hormone therapy for syndromic short stature.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1755251","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:21:53Z","timestamp":1771503713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel RAD50 variants lead to Nijmegen Breakage Syndrome\u2013like disorder and unplanned recombinant human growth hormone treatment response"],"prefix":"10.3389","volume":"17","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MingYu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShengNan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Molecular Laboratory, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongFen","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.03.014","article-title":"DNA double-strand break repair pathway choice and cancer","volume":"19","author":"Aparicio","year":"2014","journal-title":"DNA Repair"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ Mol Mutagen"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9071678","article-title":"A survey of reported disease-related mutations in the MRE11-RAD50-NBS1 complex","volume":"9","author":"Rahman","year":"2020","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31579","article-title":"RAD50 germline mutations are associated with poor survival in BRCA1\/2-negative breast cancer patients","volume":"143","author":"Fan","year":"2018","journal-title":"Int J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108559","article-title":"A disease-causing single amino acid deletion in the coiled-coil domain of RAD50 impairs MRE11 complex functions in yeast and humans","volume":"33","author":"Cruz","year":"2020","journal-title":"Cell Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.31053\/1853.0605.v79.n1.32795","article-title":"Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a case report","volume":"79","author":"Sanchez-Castro","year":"2022","journal-title":"Rev Fac Cienc Med (cordoba Argent)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ajmg.1320400109","article-title":"Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child","volume":"40","author":"Barbi","year":"1991","journal-title":"Am J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.04.010","article-title":"Human RAD50 deficiency in a nijmegen breakage syndrome-like disorder","volume":"84","author":"Waltes","year":"2009","journal-title":"Am J Hum Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61570","article-title":"Human RAD50 deficiency: confirmation of a distinctive phenotype","volume":"182","author":"Ragamin","year":"2020","journal-title":"Am J Med Genet A"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01591-8","article-title":"Bone marrow failure and immunodeficiency associated with human RAD50 variants","volume":"43","author":"Takagi","year":"2023","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2018.09.007","article-title":"Genetic analysis of undiagnosed ataxia-telangiectasia-like disorders","volume":"41","author":"Kashimada","year":"2019","journal-title":"Brain Dev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.602482","article-title":"Geographical distribution, incidence, Malignancies, and outcome of 136 eastern slavic patients with nijmegen breakage syndrome and NBN founder variant c.657_661del5","volume":"11","author":"Sharapova","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008422","article-title":"Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis","volume":"16","author":"Hohl","year":"2020","journal-title":"PloS Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00397","article-title":"Functional interaction between BRCA1 and DNA repair in yeast may uncover a role of RAD50, RAD51, MRE11A, and MSH6 somatic variants in cancer development","volume":"9","author":"Maresca","year":"2018","journal-title":"Front Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12885-018-4573-5","article-title":"Pancreatic cancer as a sentinel for hereditary cancer predisposition","volume":"18","author":"Young","year":"2018","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001412","article-title":"Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report","volume":"34","author":"Huang","year":"2023","journal-title":"Anti-Cancer Drugs"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/children12070855","article-title":"Idiopathic short stature in the genomic era: integrating auxology, endocrinology, and emerging genetic insights","volume":"12","author":"Paparella","year":"2025","journal-title":"Children (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1755251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:21:54Z","timestamp":1771503714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1755251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":19,"alternative-id":["10.3389\/fendo.2026.1755251"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1755251","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1755251"}}